Combination cancer therapy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8575164
APP PUB NO 20080267957A1
SERIAL NO

12072269

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods and compositions for treating tumors or tumor metastases in a patient, comprising administering to the patient simultaneously or sequentially (a) a therapeutically effective amount of an anti-cancer agent and (b) an IGF1R inhibitor compound of Formula I, with or without additional agents or treatments, such as other anti-cancer drugs or radiation therapy. Suitable IGF1R inhibitor may be represented by Formula I:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
OSI PHARMACEUTICALS INC106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Arnold, Lee D East Islip, US 67 2100
Buck, Elizabeth Farmingdale, US 9 15
Haley, John D Farmingdale, US 34 904
Ji, Qun-Sheng Babylon, US 5 31
Mulvihill, Mark J Farmingdale, US 30 121

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 5, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00